Funding Clinical Trials
Funding Clinical Trials
Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
CIRM Clinical Dashboard
Disease Areas![]() |
Investigator | Organization | Phase | Trial Status | Targeted Enrollment | Detail |
---|---|---|---|---|---|---|
|
Thomas Kipps | University of California, San Diego | Phase 1/2 | Active, not recruiting | 102 | |
|
David Miklos | Stanford University | Phase 1 | Recruiting | 60 | |
|
Matthew Porteus | Stanford University | Phase 1 | Recruiting | 22 | |
|
Paul Finnegan | Angiocrine Bioscience, Inc. | Phase 3 | Recruiting | 148 | |
Edward Kavalerchik | Angiocrine Bioscience, Inc. | Phase 1 | Completed | 10 | ||
Thomas Kipps | University of California, San Diego | Phase 1 | Completed | 26 | ||
Irving Weissman | Stanford University | Phase 1 | Completed | 88 | ||
|
Michael Pulsipher | Children's Hospital of Los Angeles | Phase 1/2 | Active, not recruiting | 60 | |
Edward Kavalerchik | Angiocrine Bioscience, Inc. | Phase 1 | Completed | 42 | ||
|
Mehrdad Abedi | University of California, Davis | Phase 1/2 | Recruiting | 18 | |
|
Colleen Delaney | Nohla Therapeutics Inc | Phase 2 | Closed | 146 | |
|
Mark Chao | Forty Seven Inc. | Phase 1 | Active, not recruiting | 258 | |
|
Joseph Woodard | Immune-Onc Therapeutics | Phase 1 | Recruiting | 122 | |
|
Rajesh Belani | Poseida Therapeutics, Inc. | Phase 1 | Closed | 105 |